Pretransplant portal vein recanalization-transjugular intrahepatic portosystemic shunt in patients with complete obliterative portal vein thrombosis

Transplantation

Volumn 99, Issue 11, 2015, Pages 2347-2355

  Salem, Riad ^a,b   Vouche, Michael ^a   Baker, Talia ^b   Herrero, Jose Ignacio ^c,d   Caicedo, Juan Carlos ^b   Fryer, Jonathan ^b   Hickey, Ryan ^a   Habib, Ali ^a   Abecassis, Michael ^b   Koller, Felicitas ^b   Vogelzang, Robert ^a   Desai, Kush ^a   Thornburg, Bartley ^a   Hohlastos, Elias ^a   Resnick, Scott ^a   Lewandowski, Robert J ^a   Sato, Kent ^a   Ryu, Robert K ^a   Ganger, Daniel ^a   Kulik, Laura ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

^c UNIVERSITY CLINIC OF NAVARRA   (Spain)

^d INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BRAIN DISEASE; CHILD PUGH SCORE; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; COMPLETE OBLITERATIVE PORTAL VEIN THROMBOSIS; CONTRAST MEDIUM EXTRAVASATION; ECHOGRAPHY; END STAGE LIVER DISEASE; FEMALE; FOLLOW UP; GASTROINTESTINAL HEMORRHAGE; HEART RIGHT VENTRICLE FAILURE; HEMOPERITONEUM; HUMAN; LIVER FUNCTION; LIVER TRANSPLANTATION; LUNG EMBOLISM; MAIN PORTAL VEIN; MALE; MODEL FOR END STAGE LIVER DISEASE SCORE; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PATIENT CARE; PATIENT SAFETY; PHLEBOGRAPHY; PORTAL VEIN; PORTAL VEIN THROMBOSIS; PRETRANSPLANT PORTAL VEIN RECANALIZATION; PRIORITY JOURNAL; RECANALIZATION; SURGICAL APPROACH; SURVIVAL RATE; SURVIVAL TIME; TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT; TRANSPLANT ELIGIBILITY; ADVERSE EFFECTS; CHRONIC DISEASE; KAPLAN MEIER METHOD; LIVER CIRCULATION; LIVER FUNCTION TEST; MIDDLE AGED; MORTALITY; PATHOPHYSIOLOGY; PATIENT SELECTION; PREDICTIVE VALUE; RADIOGRAPHY; RISK FACTOR; TREATMENT OUTCOME; UNITED STATES; VASCULAR PATENCY; VENOUS THROMBOSIS; YOUNG ADULT;

ADULT; AGED; CHICAGO; CHRONIC DISEASE; END STAGE LIVER DISEASE; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; LIVER CIRCULATION; LIVER FUNCTION TESTS; LIVER TRANSPLANTATION; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PATIENT SELECTION; PHLEBOGRAPHY; PORTAL VEIN; PORTASYSTEMIC SHUNT, TRANSJUGULAR INTRAHEPATIC; PREDICTIVE VALUE OF TESTS; RISK FACTORS; TREATMENT OUTCOME; VASCULAR PATENCY; VENOUS THROMBOSIS; YOUNG ADULT;

EID: 84945980532     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0000000000000729     Document Type: Article

References (25)

1. Ponziani FR, Zocco MA, Campanale C, et al. Portal vein thrombosis: insight into physiopathology, diagnosis, and treatment. World J Gastroenterol. 2010;16:143-155.
2. Amitrano L, Guardascione MA, Brancaccio V, et al. Risk factors and clinical presentation of portal vein thrombosis in patients with liver cirrhosis. J Hepatol. 2004;40:736-741.
3. Luca A, Caruso S, Milazzo M, et al. Natural course of extrahepatic nonmalignant partial portal vein thrombosis in patients with cirrhosis. Radiology. 2012;265:124-132.
4. Maruyama H, Okugawa H, Takahashi M, et al. De novo portal vein thrombosis in virus-related cirrhosis: predictive factors and long-term outcomes. Am J Gastroenterol. 2013;108:568-574.
5. Zocco MA, Di Stasio E, De Cristofaro R, et al. Thrombotic risk factors in patients with liver cirrhosis: correlation with MELD scoring system and portal vein thrombosis development. J Hepatol. 2009;51:682-689.
6. Francoz C, Valla D, Durand F. Portal vein thrombosis, cirrhosis, and liver transplantation. J Hepatol. 2012;57:203-212.
7. Garcia-Pagan JC, Valla DC. Portal vein thrombosis: a predictable milestone in cirrhosis? J Hepatol. 2009;51:632-634.
8. Hibi T, Nishida S, Levi DM, et al. When and why portal vein thrombosis matters in liver transplantation: a critical audit of 174 cases. Ann Surg. 2014;259:760-766.
9. Bauer J, Johnson S, Durham J, et al. The role of TIPS for portal vein patency in liver transplant patients with portal vein thrombosis. Liver Transpl. 2006;12:1544-1551.
10. Jamieson NV. Changing perspectives in portal vein thrombosis and liver transplantation. Transplantation. 2000;69:1772-1774.
11. Rossle M. TIPS: 25 years later. J Hepatol. 2013;59:1081-1093.
12. Bilbao JI, Quiroga J, Herrero JI, Benito A. Transjugular intrahepatic portosystemic shunt (TIPS): current status and future possibilities. Cardiovasc Intervent Radiol. 2002;25:251-269.
13. Van Ha TG, Hodge J, Funaki B, et al. Transjugular intrahepatic portosys-temic shunt placement in patients with cirrhosis and concomitant portal vein thrombosis. Cardiovasc Intervent Radiol. 2006;29:785-790.
14. Senzolo M, Tibbals J, Cholongitas E, et al. Transjugular intrahepatic portosystemic shunt for portal vein thrombosis with and without cavernous transformation. Aliment Pharmacol Ther. 2006;23:767-775.
15. Perarnau JM, Baju A, D'Alteroche L, et al. Feasibility and long-term evolution of TIPS in cirrhotic patients with portal thrombosis. Eur J Gastroenterol Hepatol. 2010;22:1093-1098.
16. Han G, Qi X, He C, et al. Transjugular intrahepatic portosystemic shunt for portal vein thrombosis with symptomatic portal hypertension in liver cirrhosis. J Hepatol. 2011;54:78-88.
17. Luca A, Miraglia R, Caruso S, et al. Short-and long-term effects of the transjugular intrahepatic portosystemic shunt on portal vein thrombosis in patients with cirrhosis. Gut. 2011;60:846-852.
18. Boyer TD, Haskal ZJ. The role of transjugular intrahepatic portosystemic shunt (TIPS) in the management of portal hypertension: update 2009. Hepatology. 2010;51:306.
19. D'Avola D, Bilbao JI, Zozaya G, et al. Efficacy of transjugular intrahepatic portosystemic shunt to prevent total portal vein thrombosis in cirrhotic patients awaiting for liver transplantation. Transplant Proc. 2012;44:2603-2605.
20. Delgado MG, Seijo S, Yepes I, et al. Efficacy and safety of anticoagulation on patients with cirrhosis and portal vein thrombosis. Clin Gastroenterol Hepatol. 2012;10:776-783.
21. Huard G, Bilodeau M. Management of anticoagulation for portal vein thrombosis in individuals with cirrhosis: a systematic review. Int J Hepatol. 2012;2012:672986.
22. Congly S, Lee S. Portal vein thrombosis: should anticoagulation be used? Curr Gastroenterol Rep. 2013;15:1-7.
23. Alves J, Boin I, Cholongitas E, et al. Surgical technique used for portal vein thrombosis when thrombectomy is not possible during liver transplantation. Surg Sci. 2011;2:767-775.
24. Robles R, Fernandez JA, Hernandez Q, et al. Eversion thrombo-endovenectomyinorganized portal vein thrombosis during liver transplantation. Clin Transplant. 2004;18:79-84.
25. Habib A, Desai K, Hickey R, et al. Portal vein recanalization-transjugularintrahepatic portosystemic shunt using the transsplenic approach to achieve transplant candidacy in patients with chronic portal vein thrombosis. J Vasc Interv Radiol. 2015;S1051-0443:01183.